Showing results (11-20 of 134) with videos related to
Sort By:
Pageof 14
Medical Hypotheses|April 17, 2007
Conversion of red bone marrow into yellow - Cause and mechanismsOlga Gurevitch, Shimon Slavin, Anatol G FeldmanPharmacological Research|November 9, 2013
Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunityShimon Slavin, Ralph W Moss, Tibor BakacsExperimental Hematology|June 9, 2004
Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantationGregory Elkin, Tatyana B Prigozhina, Shimon SlavinClinical Neurology and Neurosurgery|March 8, 2008
The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disordersShimon Slavin, Basan G S Kurkalli, Dimitrios KarussisExperimental Hematology|January 3, 2007
Osteoporosis of hematologic etiologyOlga Gurevitch, Sofia Khitrin, Andrei Valitov, et al.Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantationShimon Slavin, Shoshana Morecki, Lola Weiss, et al.Critical Reviews in Oncology/Hematology|April 25, 2003
Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and manShimon Slavin, Shoshana Morecki, Lola Weiss, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapyShai Yarkoni, Tatyana B Prigozhina, Shimon Slavin, et al.Experimental Hematology|September 24, 2008
Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantationTatyana B Prigozhina, Gregory Elkin, Sofia Khitrin, et al.Experimental Hematology|March 30, 2006
Improved survival following induction of GVHD following lipopolysaccharide immunizationAli Abdul-Hai, Lola Weiss, Shimon Slavin, et al.Pageof 14